14 Jan

Temporary suspension of certain IVF procedures in Victoria

ASX Announcement Monash IVF Group Limited (ASX: MVF) 1 4 January 2022 Temporary suspension of certain IVF procedures in Victoria Monash IVF Group Limited (ASX: MVF, the “Company” or “Monash IVF”) today provides an update on IVF procedures in Victoria following changes to non - urgent surgery settings to assist Victorian hospitals respond to Omicron. On 12 January 2022, the Victorian Minister of Health made the Pandemic (Additional Industry Obligati ons) Order 2022 (N o .3) (“Order”) under the Public Health and Wellbeing Act 2008 in the belief that the Order is reasonably necessary to protect public health throughout Victoria from the serious risk arising from the COVID - 19 pandemic disease. The Order ha s the following impact on IVF and is limited to metropolitan Melbourne and major regional cities across Victoria: • Stimulated Cycles whereby patients have commenced their drug regime prior to 6 January 2022 will continue to complete their stimulated cycle treatment in line with COVID - 19 safety protocols; • For all patients who plan to commence a Stimulated Cycle after 6 January 2022, they will need to undertake a clinical assessment to determine the urgency and whether they can commence treatment based on cl ause 16(7)(a)(ii) of the Order; • Frozen Embryo Transfer (FET), Intrauterine Insemination (IUI) and medical fertility preservation procedures are continu ing at this time; • The Order commences from 12 January 2022 and ends at 11:59pm on 12 April 2022. It is ye t to be determined if this Order will impact IVF services for the full three - month period. Monash IVF’s primary objective remains supporting and keeping patients informed and updated on their treatment options during this uncertain time . The Company remains focussed on maintaining appropriate measures and protocols in - place to protect the health and safety of the Company’s patients, employees and specialists . Whilst this is the Company’s primary objective, the Company will continue to seek clarity from the Department of Health on the application of the Order and will continue to work with the Department of Health on a swift recommencement of all IVF services in Victoria . Similar to the temporary suspension of IVF procedures in March and April 2020, it is the Company’s view that the Order will create pent - up treatment demand which will be ser vices within three to four months following resumption of services . The Company ’ s IVF Services in all other Australian States (outside of Victoria) and other relevant countries are not currently impacted by elective surgery restrictions and are continuing. The short - term financial impact of the Order on the FY2022 Financial Result is yet to be determined but is not expected to have a material effe ct on the FY2022 Financial Result unless the Order restrict s IVF services for a period great er than e ight weeks from the commencement of the Order . The Company will provide a further update in due course and/or at the Company’s half - year results announcement . Approved by the Chairman and Managing Director . Michael Knaap Chief Executive Officer and Managing Director , Monash IVF Group +61 3 94 52 8132 Malik Jainudeen Chief Financial Officer and Company Secretary , Monash IVF Group +61 3 9 452 8132
Information on this Website is provided for general information purposes only and is not a substitute for professional advice. ASX Information (including company announcements and prices) is delayed by at least 20 minutes. JSE Information (including company announcements and prices) is delayed by at least 15 minutes. Reliance on the information you access on or from this Website is solely at your own risk. We make no representation or warranty in relation to the future performance of the companies that appear on this Website. Investment in securities involves risk and you should obtain independent professional legal, financial, investment or company advice before acting on any of the information you access on this Website. Using, browsing or otherwise accessing this Website is subject to our Terms and Conditions and our Privacy Policy.

© 2022 Listcorp. ABN 60 166 140 307

Never miss news from Monash IVF Group Limited (ASX:MVF) when you join Listcorp.